Dr. Marroquin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S. Maryland Ave.
Chicago, IL 60637
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2022 - 2025
Icahn School of Medicine at Mount Sinai/Morningside/WestChief Residency, Internal Medicine, 2021 - 2022- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2018 - 2021
Johns Hopkins UniversityPost-Doctoral Fellowship, Hematology and Medical Oncology, 2016 - 2018
Tecnologico de Monterrey Escuela de MedicinaClass of 2017
Certifications & Licensure
IL State Medical License 2022 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 41 citationsHotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivationW. Brian Dalton, Eric Helmenstine, Noel Walsh, Lukasz P. Gondek, Dhanashree S. Kelkar
The Journal of Clinical Investigation. 2019-11-01 - 7 citationsRisk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait
Blood Advances. 2021-09-22 - 72 citationsDonor Clonal Hematopoiesis and Recipient Outcomes After TransplantationChristopher J. Gibson, Haesook T. Kim, Lin Zhao, H. Moses Murdock, Bryan C. Hambley
Journal of Clinical Oncology. 2021-11-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
